Know your risk to reduce your risk of type 2 diabetes
By being informed of your personal risk of type 2 diabetes, you can make informed, proactive health decisions and seek support when you need it.
Did you know…
Type 2 diabetes can be prevented in up to 58% of people with pre-diabetes (that is, at high risk of developing type 2 diabetes).1
Do you know which factors influence your risk of type 2 diabetes?
Is geneType for Type 2 Diabetes right for you?
GeneType for Type 2 Diabetes is appropriate for:
- Men and Women
- Adults 40-85 years old
Simple, Actionable Results
GeneType reports help you and your health provider translate your personal clinical, family and genetic data into an actionable preventable health plan.
Sample patient report
Uniquely powered
to assess your risk
Understand your baseline risk of developing type 2 diabetes.
Take risk-reducing steps that are personalized to your health.
Have questions? We have answers.
If your question is not shown here, please contact us directly.
Does this test include all the risk factors for type 2 diabetes?
Type 2 diabetes is a multifactorial disease and it is not possible to incorporate all potential risk factors into a risk prediction model.
Who is this test not suitable for?
This test is not applicable to people who have fasting glucose levels above 7.0 mmol/L. In this case, the person already has type 2 diabetes and should consult their health provider.
Will insurance cover this test?
No.
At this time geneType is a self-pay test. However, your patient may use FSA/HSA to pay for the test.
Know your risk of type 2 diabetes so you can take action
*Patient eligibility dependent on personal medical history, age and sex
Interested in ordering more than one disease? Order geneType Multi-Test.
See individual disease pages for more information about each test.
The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for 8 diseases in the panel; a man would be eligible for 7. Starting at age 30, a patient may qualify for geneType's cancer risk assessments only.
References
- Knowler WC et al. N Engl J Med 2002;346:393–403.
Accredited For Compliance With NPAAC Standards And ISO 15189
